The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: -0.50 (-3.08%)
Spread: 0.50 (3.226%)
Open: 16.25
High: 16.25
Low: 15.70
Prev. Close: 16.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

Wed, 15th Jul 2020 11:47

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Finsbury Food Group PLC - bakery and food service firm - Expects annual revenue to be GBP306.3 million, down from GBP315.3 million, due to declines in UK Bakery and Overseas division. First half revenue grew by 4.7% to GBP159.4 million, but second half was affected by Covid-19, with revenue falling by 9.8% to GBP146.9 million

----------

Open Orphan PLC - pharmaceutical services - Signs option to acquire CHIMagents Ltd for nominal sum. CHIMagents recently established to assist in design and manufacture of challenge agents for use in challenge studies. Open Orphan has three months to exercise the option.

----------

Air Partner PLC - aviation services - Security business Redline appointed to develop and deliver security management system for ISS Australia & New Zealand. ISS is a facility services provider, which provides security, screening and facility services across airports and ports. Trading remains ahead of budget with underlying pretax profit of GBP10 million in the first five months of 2020.

----------

Cambridge Cognition Holdings PLC - brain health firm based in Cambridge - Collaborates with 4YouandMe and Center for International Emergency Medical Services to investigate use of wearables and mobile phones to measure stress recovery in health works in the US caring for Covid-19 positive patients. Virtual study to take place over six months with up to 500 participants.

----------

Destiny Pharma PLC - Brighton-based biotechnology firm - Notes launch of USD1 billion AMR Action Fund to provide financial resources and technical support to help biotechnology companies bring novel anti-infective drugs to patients.

----------

Kodal Minerals PLC - mineral exploration and development - Signs USD1.5 million unsecured convertible loan agreement with Riverfort Global Opportunities PCC and YAII PN Ltd, which will allow for the continued development of its flagship Bougouni lithium project in Mali, and its gold projects in Mali and the Ivory Coast.

----------

Woodbois Ltd - Africa-focused timber producer - Raises GBP13.1 million through placing, retail offer and subscription of 655.0 million shares at a price of 2.0 pence per share, which will go towards expanding its production capacity and margins in Gabon, as well as grow its trading activities worldwide. Intends to pay dividend at end of 2021 financial year.

----------

Premier African Minerals Ltd - southern Africa-focused miner - Ministry of Industry, Commerce & Enterprise Development confirms that National Indigenisation & Economic Development Fund-appointed directors at RHA Tungsten Pvt Ltd can continue to act in their capacity. This removes one obstruction to finding a mutually acceptable solution to RHA's funding and equity dilemma.

----------

Caspian Sunrise PLC - oil & gas exploration - All Kazakh regulatory and shareholder approvals have been received, and relevant paperwork sent to UAE to complete the required re-registration of ownership of the Caspian Explorer, allowing for the acquisition of the asset.

----------

Allergy Therapeutics PLC - Sussex-based biotechnology firm - Expects earnings to be ahead of market expectations For year ended June 30. Revenue set to be GBP78.2 million, up 6% from GBP73.7 million. To repay all UK furlough monies claimed back to the government. Grass MATA MPL clinical programme expected to start next month as planned.

----------

AFC Energy PLC - hydrogen power generation technology developer - Forms collaboration with electric international rally series Extreme E to supply hydrogen fuelled, off-grid power for electric SUV racing due to start in early 2021.

----------

Carr's Group PLC - agriculture and engineering firm - For 19-week period ended July 11, trading remains in line with management expectations for financial year ending August 29. Agriculture division ahead of expectations, but Engineering unit affected by temporary interruptions to nuclear and defence projects. To pay interim dividend of 2.25p per share on October 2.

----------

BATM Advanced Communications Ltd - Israel-based data and telecommunications company - Develops three new test kits for Covid-19. Serologic test upgraded to measure quantity of antibodies in blood instead of just presence or absence. Antigen test upgraded to detect spike S gene to allow for diagnosis of Covid-19 in people with low viral loads. New molecular diagnostics test to identify specific respiratory virus. Sales and production to begin at start of fourth quarter of 2020.

----------

Mission Group PLC - creative agency - Expects revenue for first half of 2020 to be GBP29 million, down from GBP39 million the year before. Anticipates pretax loss of GBP2.2 million in interim period versus profit of GBP3.4 million. However, for 2020 as a whole, expects to deliver a profitable performance but at lower levels than 2019.

----------

Alpha FX Group PLC - currency risk management and payments - For first half of 2020, revenue increased by 16% to GBP18.0 million from GBP15.6 million, as average revenue per client rose with net increase of 28 clients to 671. Continues to invest in back office headcount and graphic expansion despite challenging environment.

----------

Bezant Resources PLC - operator of Kalengwa copper-gold project in Zambia and Hope copper-gold project in Namibia - Due diligence on Hope project progressing as planned, with combined mineral resource of 10.2 million tonnes at 1.9% copper and 0.3 grams per tonne of gold. From metallurgical test work, excellent recoveries made of 96% copper and 84% gold to a 28% copper grade.

----------

Portmeirion Group PLC - homewares manufacturer and distributor based in Stoke-on-Trent - Sales for six months to June to be down 8% at GBP32 million from GBP34.9 million. Like-for-like sales down 20%, excluding sales from Nambe division acquired in July 2019. Expects to report low single million pound pretax loss compared to profit of GBP500,000.

----------

Real Estate Investors PLC - Midlands-focused real estate investment trust - Rent collection for quarter to the end of June rises to 90.2% from 81% reported on June 15. Meanwhile rent collection for quarter ending September is 82% so far. Expects to pay 0.5 pence per share dividend on July 24.

----------

SEC Newgate Spa - communications, advocacy and research - Launches TRUE, an AI-powered platform to run new-to-market semantic and reputation assessments. Initially function in Italian, but can work five other languages, including English, French, German and Spanish. English version expected to be available in fourth quarter of 2020.

----------

Hydrogen Group PLC - recruitment firm - For the first six months of 2020, net fee income at GBP11.7 million, down from GBP15.3 million, as Covid-19 pandemic impacted client demand from Asia Pacific in January, which spread to its EMEA and US businesses over time.

----------

Arcontech Group PLC - market data software firm - Profit for year to the end of June set to be in line with market expectations, while net cash as at June 30 is GBP5.0 million, up from GBP4.1 million.

----------

GCP Asset Backed Income Fund Ltd - Asset backed loans investor - Net asset value per share as at June 30 was 100.83 pence. Will continue to keep in place discount rate movements on loans made to different investments due to continued uncertainty from Covid-19 pandemic.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2019 16:06

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Read more
2 Dec 2019 15:57

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Read more
16 Oct 2019 14:48

Destiny Pharma pleased with latest XF-73 results at it proceeds with next phase

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma reported on the publication of results from a positive phase 1 clinical study in 60 healthy United States volunteers using a nasal gel formulation of its lead drug, XF-73 (exeporfinium chloride), on Wednesday.

Read more
16 Oct 2019 11:36

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Read more
23 Sep 2019 16:09

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Read more
23 Sep 2019 12:12

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Read more
10 Sep 2019 14:16

Destiny Pharma Collaboration With University Of Sheffield Wins Funding

(Alliance News) - Destiny Pharma PLC on Tuesday said it has been awarded a grant along with the University of Sheffield for their research collaboration on drug-resistant infections.Shares

Read more
9 Apr 2019 11:17

Destiny Pharma Annual Loss Doubles On Higher Costs, Confident Outlook

LONDON (Alliance News) - Destiny Pharma PLC on Tuesday reported a significantly widened annual loss as expenses surged in the run-up to the development of its lead candidate.For 2018, the a

Read more
9 Apr 2019 09:32

Destiny Pharma 'well funded' despite wider loss

(Sharecast News) - Destiny Pharma on Tuesday reported a wider annual loss as it increased research and development costs, although the company is "well funded" through to the second half of next year.

Read more
2 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 3 April AAFull Year ResultsCMC MarketsTrading GroupTrading Year Year 4

Read more
27 Mar 2019 11:53

Destiny Pharma, MedPharm To Develop New XF-Platform Drug Formulations

LONDON (Alliance News) - Destiny Pharma PLC on Wednesday said it has partnered with MedPharm to develop new formulations of its XF-platform compounds.MedPharm is a contract provider of and

Read more
28 Jan 2019 11:46

Destiny Pharma Gets Positive Results From Second Phase Trial Of XF-73

LONDON (Alliance News) - Destiny Pharma PLC on Monday reported positive results in a second phase 1 clinical study examining the anti-irritation features of its XF-73 nasal gel.The study, a

Read more
28 Jan 2019 10:39

Destiny Pharma sees success in latest trial of XF-73 nasal gel

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma announced positive data and the non-irritant classification for its XF-73 nasal gel on Monday.

Read more
25 Jan 2019 10:58

Destiny Pharma leaps on £1.6m grant and UK-China collaboration

(Sharecast News) - Destiny Pharma jumped on Friday after being awarded funding of up to £1.6m from a collaboration established under the UK-China AMR grant fund.

Read more
25 Jan 2019 09:53

Destiny Pharma Gets Funding For Antimicrobial Resistance Research

LONDON (Alliance News) - Destiny Pharma PLC said Friday that it has secured a GBP1.6 million grant for examining novel drugs to prevent, control and eradicate life threatening bacteria or without

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.